New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
10x Genomics, Inc.
TXG
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

2B

Medical - Healthcare Information Services

Next Earning date - 29 Oct 2024

2B

Medical - Healthcare Information Services

Next Earning date - 29 Oct 2024

14.83USD
Shape-0.31 ( -2.05%)
Market Open
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-75%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

74%

Quote Panel

Shape
Updated October 23, 2024
1W -0.24 % 1M -35.46 % 3M -21.85 % 1Y -63.32 %

Key Metrics

Shape
  • Market Cap

    1.79B


  • Shares Outstanding

    120.61M


  • Share in Float

    112.88M


  • Dividende

    0


  • Earning Date

    29 Oct 2024


  • Price Target

    14.83


  • Average Volume

    1.79M


  • Beta

    1.845


  • Range

    14.02-57.9


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.10xgenomics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.89x

P/S Ratio

2.51x

P/B Ratio

0.1

Debt/Equity

-38.0%

Net Margin

$-2.0

EPS

How TXG compares to sector?

P/E Ratio

Relative Strength

Shape

TXG

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$705M

Shape360%

2025-Revenue

$0.95

Shape-197%

2025-EPS

$150M

Shape-385%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

upgrade

Previous: Hold

2024-07-22

Now: Buy

Deutsche Bank

downgrade

Previous: Buy

2024-07-10

Now: Hold

Wolfe Research

downgrade

Previous: Not converted

2024-06-27

Now: Peer Perform

Guggenheim

downgrade

Previous: Not converted

2024-06-25

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.37
vs -0.15

Q4.22

arrow
arrow

N/A

-0.15
vs -0.16

Q1.23

arrow
arrow

N/A

-0.44
vs -0.38

Q2.23

arrow
arrow

N/A

-0.53
vs -0.57

Q3.23

arrow
arrow

N/A

-0.51
vs -0.37

Q4.23

arrow
arrow

N/A

-0.41
vs -0.15

Q1.24

arrow
arrow

N/A

-0.50
vs -0.44

Q2.24

arrow
arrow

N/A

-0.32
vs -0.53

Q3.24

arrow
arrow

N/A

-0.34
vs -0.51

Q4.24

arrow
arrow

N/A

-0.22
vs -0.41

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+5%

131.1M  vs 125.3M

Q4.22

arrow
arrow

+9%

156.2M  vs 143.5M

Q1.23

arrow
arrow

+17%

134.3M  vs 114.5M

Q2.23

arrow
arrow

+28%

146.8M  vs 114.6M

Q3.23

arrow
arrow

+17%

153.6M  vs 131.1M

Q4.23

arrow
arrow

+18%

184M  vs 156.2M

Q1.24

arrow
arrow

+5%

141M  vs 134.3M

Q2.24

arrow
arrow

+4%

153.1M  vs 146.8M

Q3.24

arrow
arrow

+3%

158.8M  vs 153.6M

Q4.24

arrow
arrow

0%

183.7M  vs 184M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.08

Q4.22

arrow
arrow

-2%

-0.02
vs -0.05

Q1.23

arrow
arrow

-6%

-0.06
vs -0.02

Q2.23

arrow
arrow

-8%

-0.08
vs -0.06

Q3.23

arrow
arrow

-12%

-0.12
vs -0.08

Q4.23

arrow
arrow

-7%

-0.07
vs -0.12

Q1.24

arrow
arrow

-8%

-0.08
vs -0.07

Q2.24

arrow
arrow

-5%

-0.05
vs -0.08

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

218

218
vs 236

-8%

Q4.22

arrow
arrow

265

265
vs 218

22%

Q1.23

arrow
arrow

256

256
vs 265

-3%

Q2.23

arrow
arrow

277

277
vs 256

8%

Q3.23

arrow
arrow

262

262
vs 277

-5%

Q4.23

arrow
arrow

278

278
vs 262

6%

Q1.24

arrow
arrow

293

293
vs 278

5%

Q2.24

arrow
arrow

262

262
vs 293

-11%

Earnings Growth

Latest News